Just gets' frustrating after 2 years of the exact same thing day in day out. I'm not saying that ENZC should realize their full value right now, but based on everything we now know, the patents, toxicity tests, collaborators/partners, etc...., we should be sitting at a very conservative .25-.40; and that is ULTRA-Conservative.
C3 mABS for HIV only puts us at $9.5B per year for first 11 years, which would give us a pps of roughly $3.36 without any type of PE/multiplier factored in. This doesn't even factor in IPF, mABS for plandemic19 or any other virus/disease, AI platform, etc... Yet we're sitting in the .04s?
Audit was completed months ago, yet Charles is still sitting on SEC Reporting? Still sitting QB? Still refuses to address any of the BS/control of our pps? It just gets old...
But yes, I know you were only kidding.... It's all good.... Here's to hoping that muzzle drops sooner vs later....
News 
Market Data 
Discover 
